Oxidative stress occurs early in Down syndrome pregnancy: A redox proteomics analysis of amniotic fluid
The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
Purpose: The present study aims to evaluate a set of oxidative stress biomarkers in the amniotic fluid (AF) of women carrying Down syndrome (DS) fetuses that could prove in vivo the early occurrence of oxidative damage in DS. Experimental design: To assess the extent of protein oxidation in DS AF, we measured protein carbonylation and protein‐bound HNE by slot‐blot analysis, total and oxidized GSH levels by enzymatic assay and heat shock proteins (HSPs) thioredoxin (Trx) induction by Western blot. Further, by a redox proteomics approach specific targets of protein carbonylation were identified. Results: We found increased levels of oxidative stress, as indexed by increased protein oxidation, lipid peroxidation, reduction of GSH and Trx levels and induction of the HSP response. By a redox proteomics approach, we identified selective proteins which showed increased oxidation in DS fetuses compared with healthy controls. The identified proteins are involved in iron homeostasis (ceruloplasmin and transferin), lipid metabolism (zinc‐α2‐glycoprotein, retinol‐binding protein 4 and apolipoprotein A1) and inflammation (complement C9, α‐1B‐glycoprotein, collagen α‐1V chain) with critical relevance in the clinical outcome of DS. Conclusions and clinical relevance: Our results indicate that oxidative damage is an early event in the DS pathogenesis and might contribute to the development of deleterious DS phenotypes, including abnormal development and AD‐like neuropathology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increased oxidative damage occurs early in DS development, as evidenced by the fact that neurons obtained from aborted fetuses with DS show evidence of increased oxidative damage63 as does amniotic fluid from mothers carrying fetuses with DS64.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [63]
Citations
Cites
[37] Carbonyl assays for determination of oxidatively modified proteins
Levine, R. L., Williams, J. A., Stadtman, E. P., & Shacter, E. (1994) · Methods in Enzymology · doi:10.1016/s0076-6879(94)33040-9 · Cited by 2,699 · cited 1×
“[17].”
Oxidative stress in neurodegeneration: Cause or consequence?
Andersen, J. K. (2004) · Nature Medicine · doi:10.1038/nrn1434 · Cited by 1,869 · cited 1×
“[32] suggested that OS in fetal DS results from low levels of reducing agents, rather than of SOD-1 overexpression [33].”
BackgroundBiochemistry of oxidative stress
Halliwell, B. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351147 · Cited by 1,543 · cited 1×
“Once formed, this compound can react with reduced form of redox-active transition metal ions, producing the dangerous oxidant, hydroxyl radical [8] that causes oxidative damage to biological macromolecules.”
BackgroundRetinol-binding protein: the transport protein for vitamin A in human plasma
Kanai, M., Raz, A., & Goodman, D. S. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105889 · Cited by 899 · cited 1×
“[58] It is mainly produced in the liver but has recently been identified as an adipokine [59], which is able to modulate glucose metabolism.”
BackgroundApoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro
Busciglio, J., & Yankner, B. A. (1995) · Nature · doi:10.1038/378776a0 · Cited by 741 · cited 1×
“In addition, DS neurons exhibit a consistent increase in intracellular ROS and elevated levels of lipid peroxidation that precede neuronal death [26].”
BackgroundBains, J. S., & Shaw, C. A. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00045-3 · Cited by 717
Colman, R. W., & Schmaier, A. H. (1997) · Blood · doi:10.1182/blood.v90.10.3819 · Cited by 581 · cited 1×
“Through these interactions, HK modulates cellular adhesion, leukocyte extravasation and vascular permeability [68, 69].”
BackgroundInsulin-like Growth Factor Binding Protein-1: Recent Findings and New Directions
Lee, P. D. K., Giudice, L. C., Conover, C. A., & Powell, D. R. (1997) · Experimental Biology and Medicine · doi:10.3181/00379727-216-44182 · Cited by 523 · cited 1×
“IGFBP-1 regulates minute-to-minute bioavailability of IGFs in the circulation and inhibits IGF actions [50].”
BackgroundLauderback, C. M., Hackett, J. M., Huang, F. F., Keller, J. N., Szweda, L. I., Markesbery, W. R., & Butterfield, D. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00451.x · Cited by 464 · cited 1×
“The IP was performed as described previously [24].”
MethodSelf-citationLassarre, C., Hardouin, S., Daffos, F., Forestier, F., Frankenne, F., & Binoux, M. (1991) · Pediatric Research · doi:10.1203/00006450-199103000-00001 · Cited by 411 · cited 1×
“IGFs are a family of mitogenic polypeptides that have been shown to be important determinants of fetal growth during human pregnancy[51–53].”
BackgroundCellular thiols and redox-regulated signal transduction
(2001) · Current Topics in Cellular Regulation · doi:10.1016/s0070-2137(01)80001-7 · Cited by 343 · cited 1×
“GSH and Trx systems also regulate signal transduction via intracellular redox balance [31].”
BackgroundCanettieri, G., Di Marcotullio, L., Greco, A., Coni, S., Antonucci, L., Infante, P., Pietrosanti, L., De Smaele, E., Ferretti, E., Miele, E., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2013 · Cited by 322 · cited 1×
“For total glutathione, an aliquot (0.1 mL) of sample was added to 0.1 mL of a solution containing 5 mM EDTA in 100 mM potassium phosphate, pH 7.5 (buffer 1) and 10 mM 5,50-dithiobis 2-nitrobenzoic acid (DTNB).”
MethodInfluentialSelf-citationRetinoids and retinoid-binding protein expression in rat adipocytes.
Tsutsumi, C., Okuno, M., Tannous, L., Piantedosi, R., Allan, M., Goodman, D. S., & Blaner, W. S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)46017-6 · Cited by 317 · cited 1×
“[58] It is mainly produced in the liver but has recently been identified as an adipokine [59], which is able to modulate glucose metabolism.”
BackgroundTHE GENETICS OF DISULFIDE BOND METABOLISM
Rietsch, A., & Beckwith, J. (1998) · Annual Review of Genetics · doi:10.1146/annurev.genet.32.1.163 · Cited by 267 · cited 1×
“Several reports highlight the key role of sulfydryl groups in response to OS [27, 28].”
BackgroundIntrinsic defect of the immune system in children with Down syndrome: a review
Kusters, M. A. A., Verstegen, R. H. J., Gemen, E. F. A., & De Vries, E. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.03890.x · Cited by 252 · cited 1×
“These results are in line with those reporting increased susceptibility of Down subjects to acquired immunodeficiency with also increased incidence of autoimmune diseases [65, 66].”
ResultBiological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients.
Hirai, K., Hussey, H., Barber, M. D., Price, S. A., & Tisdale, M. J. (1998) · PubMed · Cited by 244
Free Radicals: Key to Brain Aging and Heme Oxygenase as a Cellular Response to Oxidative Stress
Poon, H. F., Calabrese, V., Scapagnini, G., & Butterfield, D. A. (2004) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/59.5.m478 · Cited by 236 · cited 1×
“The expression of HO-1 is upregulated during OS, as well as by GSH depletion [36–38].”
BackgroundSelf-citationUnderstanding the Basis for Down Syndrome Phenotypes
Roper, R. J., & Reeves, R. H. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020050 · Cited by 233 · cited 1×
“DS is better described as a multifactorial disease characterized by an abnormal expression of trisomic genes arising not only from genetic but also environmental factors [2].”
BackgroundCalabrese, V., Sultana, R., Scapagnini, G., Guagliano, E., Sapienza, M., Bella, R., Kanski, J., Pennisi, G., Mancuso, C., Stella, A. M. G., et al. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1975 · Cited by 227
Self-citationStructure to function relationships in ceruloplasmin: a 'moonlighting' protein
Bielli, P., & Calabrese, L. (2002) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-002-8519-2 · Cited by 210
Williamson, R., Lee, D., Hagaman, J., & Maeda, N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.7134 · Cited by 207 · cited 1×
“ApoA1 knockout mice also exhibit a marked reduction in plasma HDL levels [62, 63] that is reflected in levels of total plasma cholesterol.”
BackgroundButterfield, D. A., Galvan, V., Lange, M. B., Tang, H., Sowell, R. A., Spilman, P., Fombonne, J., Gorostiza, O., Zhang, J., Sultana, R., et al. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.10.035 · Cited by 188
Self-citationBiomarkers of oxidative stress are significantly elevated in Down syndrome
Jovanovic, S. V., Clements, D., & MacLeod, K. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00137-3 · Cited by 183 · cited 2×
“Several studies demonstrated a major role of oxidative stress (OS) in DS clinical phenotypes [3–6].”
BackgroundDown syndrome and Alzheimer's disease: A link between development and aging
Lott, I. T., & Head, E. (2001) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.1025 · Cited by 158 · cited 1×
“Indeed, the proposed scenario could correlate with some characteristic features of DS including early ageing [71], neurological and cognitive impairment [72], increased risk for cancer and immunodeficiency [73, 74].”
BackgroundOxidative stress: A bridge between Down's syndrome and Alzheimer's disease
Zana, M., Janka, Z., & Kalman, J. L. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.03.008 · Cited by 155 · cited 1×
“Although OS is known to play a major role in DS [6], the molecular mechanisms underlying the pathological alterations and how the oxidative imbalance can contribute to the clinical manifestation of DS are not yet known [1].”
BackgroundTham, A., Nordberg, A. K., Grissom, F. E., Carlsson‐Skwirut, C., Viitanen, M. H., & Sara, V. R. (1993) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02257671 · Cited by 155 · cited 1×
“The present findings extend and reinforce the observation that levels of circulating insulin, IGF-I and IGFBPs are altered in many types of human neurodegenerative diseases, including major illnesses such as Alzheimer disease or stroke as well as inherited neurodegenerative diseases [55, 56].”
ResultHeme Oxygenase and Its Products in the Nervous System
Mancuso, C. (2004) · Antioxidants and Redox Signaling · doi:10.1089/1523086041798097 · Cited by 122
Proteomic profile determination of autosomal aneuploidies by mass spectrometry on amniotic fluids
Mangé, A., Desmetz, C., Bellet, V., Molinari, N., Maudelondé, T., & Solassol, J. (2008) · Proteome Science · doi:10.1186/1477-5956-6-1 · Cited by 121 · cited 1×
“In addition, other groups employed proteomic technology in prenatal diagnosis to identify putative biomarkers for early and accurate detection of fetuses at risk of chromosomal abnormalities [44–46].”
BackgroundHancock, J. T., Desikan, R., & Neill, S. J. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00646-3 · Cited by 121 · cited 1×
“Therefore, the intracellular pool of GSH is thought to reflect the oxidative pressure within a cell [29, 30].”
BackgroundEarly Glycoxidation Damage in Brains from Down's Syndrome
Odetti, P. R., Angelini, G., Dapino, D., Zaccheo, D., Garibaldi, S., Dagna-Bricarelli, F., Piombo, G., Perry, G. L., Smith, M. A., Traverso, N., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8186 · Cited by 118 · cited 1×
“[25] showing enhanced protein carbonylation (besides lipoperoxidation and glycoxidation Table 2.”
BackgroundKashino, Y., Koike, H., & Satoh, K. (2001) · Electrophoresis · doi:10.1002/1522-2683()22:6<1170::aid-elps1170>3.0.co;2-1 · Cited by 108
Proteomic analysis of amniotic fluid in pregnancies with Down syndrome
Tsangaris, G. T., Karamessinis, P., Kolialexi, A., Garbis, S. D., Antsaklis, A. J., Mavrou, A., & Fountoulakis, M. (2006) · PROTEOMICS · doi:10.1002/pmic.200600085 · Cited by 106 · cited 8×
“Two-sided Student’s t-tests were used to analyze differences in protein levels between DS and CTR.”
BackgroundResultInfluentialHuman neutrophils contain and bind high molecular weight kininogen.
Gustafson, E. J., Schmaier, A. H., Wachtfogel, Y. T., Kaufman, N., Kucich, U., & Colman, R. W. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114151 · Cited by 104 · cited 1×
“Through these interactions, HK modulates cellular adhesion, leukocyte extravasation and vascular permeability [68, 69].”
BackgroundMolecular changes in fetal Down syndrome brain
Engidawork, E., & Lübec, G. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01614.x · Cited by 101
Mitochondrial dysfunction and Down's syndrome
Arbuzova, S., Hutchin, T. P., & Cuckle, H. (2002) · BioEssays · doi:10.1002/bies.10138 · Cited by 99 · cited 1×
“Mitochondrial dysfunction has been reported to occur already during embryonic development [13].”
BackgroundRedox regulation and oxidant activation of heme oxygenase-1
Tyrrell, R. (1999) · Free Radical Research · doi:10.1080/10715769900300901 · Cited by 99 · cited 1×
“The expression of HO-1 is upregulated during OS, as well as by GSH depletion [36–38].”
BackgroundUric acid and allantoin levels in Down syndrome: antioxidant and oxidative stress mechanisms?
Žitňanová, I., Korytár, P., Aruoma, O. I., Šustrová, M., Garaiová, I., Muchová, J., Kalnovičová, T., Pueschel, S., & Ďuračková, Z. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2003.11.020 · Cited by 96 · cited 1×
“A significant increase in oxidative DNA damage (urinary 8-OHdG), lipid peroxidation and isoprostane 8,12-iso-iPF2aVI levels [3, 5, 9–12] was reported in urine obtained from DS children and DS amniotic fluid (AF) samples, respectively, indicating a ‘‘pro-oxidant state’’ which, associated with overwhelmed antioxidant de…”
BackgroundBalcz, B., Kirchner, L., Cairns, N. J., Fountoulakis, M., & Lübec, G. (2001) · Springer eBooks · doi:10.1007/978-3-7091-6262-0_15 · Cited by 95 · cited 1×
“A significant increase in oxidative DNA damage (urinary 8-OHdG), lipid peroxidation and isoprostane 8,12-iso-iPF2aVI levels [3, 5, 9–12] was reported in urine obtained from DS children and DS amniotic fluid (AF) samples, respectively, indicating a ‘‘pro-oxidant state’’ which, associated with overwhelmed antioxidant de…”
BackgroundDistinct Abnormalities in the Innate Immune System of Children with Down Syndrome
Bloemers, B. L. P., van Bleek, G. M., Kimpen, J. L. L., & Bont, L. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.12.006 · Cited by 95 · cited 1×
“These results are in line with those reporting increased susceptibility of Down subjects to acquired immunodeficiency with also increased incidence of autoimmune diseases [65, 66].”
ResultEarly oxidative stress in amniotic fluid of pregnancies with Down syndrome
Perrone, S., Longini, M., Bellieni, C. V., Centini, G., Kenanidis, A., Marco, L. D., Petraglia, F., & Buonocore, G. (2006) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2006.10.019 · Cited by 94 · cited 1×
“A significant increase in oxidative DNA damage (urinary 8-OHdG), lipid peroxidation and isoprostane 8,12-iso-iPF2aVI levels [3, 5, 9–12] was reported in urine obtained from DS children and DS amniotic fluid (AF) samples, respectively, indicating a ‘‘pro-oxidant state’’ which, associated with overwhelmed antioxidant de…”
BackgroundOxidative stress and neural dysfunction in Down Syndrome
Iannello, R. C., Crack, P. J., de Haan, J. B., & Kola, I. (1999) · Springer eBooks · doi:10.1007/978-3-7091-6380-1_17 · Cited by 93 · cited 1×
“Several studies demonstrated a major role of oxidative stress (OS) in DS clinical phenotypes [3–6].”
BackgroundMalignancy in Children with Trisomy 21
Rabin, K. R., & Whitlock, J. A. (2009) · The Oncologist · doi:10.1634/theoncologist.2008-0217 · Cited by 93
Plump, A. S., Azrolan, N., Odaka, H., Wu, L., Jiang, X. L., Tall, A. R., Eisenberg, S., & Breslow, J. L. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37227-8 · Cited by 93
Langford, K., Blum, W. F., Nicolaides, K. H., Jones, J. L., McGregor, A., & MIELL, J. P. (1994) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1994.tb02030.x · Cited by 92
Peptide Mass Fingerprinting Using MALDI-TOF Mass Spectrometry
Pappin, D. J. C. (2003) · Protein Sequencing Protocols · doi:10.1385/0-89603-353-8:165 · Cited by 92 · cited 2×
“Identifications were validated when the probabilitybased Mowse protein score was significant according to MASCOT [23].”
MethodInfluentialGulesserian, T., Seidl, R., Hardmeier, R., Cairns, N., & Lubec, G. (2001) · Journal of Investigative Medicine · doi:10.2310/6650.2001.34089 · Cited by 90 · cited 6×
“This result is consistent with previous studies showing that the properties of kininogens were altered by oxidation of their methionine residues by ROS [70].”
BackgroundInfluentialHayes, A., & Batshaw, M. L. (1993) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(16)38548-0 · Cited by 87
Perluigi, M., Domenico, F. D., Blarzino, C., Foppoli, C., Cini, C., Giorgi, A., Grillo, C., Marco, F. D., Butterfield, D. A., Schininà, M. E., et al. (2010) · Proteome Science · doi:10.1186/1477-5956-8-13 · Cited by 82 · cited 1×
“To identify valid spots, PDQuest spot detection software was used as reported in our previous works [20].”
MethodSelf-citationMultiple evidence for an early age pro-oxidant state in Down Syndrome patients
Pallardó, F. V., Degan, P., d’Ischia, M., Kelly, F. J., Zatterale, A., Calzone, R., Castello, G., Fernández‐Delgado, R., Dunster, C., Lloret, A., et al. (2006) · Biogerontology · doi:10.1007/s10522-006-9002-5 · Cited by 81 · cited 2×
“Several studies demonstrated a major role of oxidative stress (OS) in DS clinical phenotypes [3–6].”
BackgroundDemple, B. (1998) · Science · doi:10.1126/science.279.5357.1655 · Cited by 66 · cited 1×
“Several reports highlight the key role of sulfydryl groups in response to OS [27, 28].”
Calabrese, V., Mancuso, C., Ravagna, A., Perluigi, M., Cini, C., Marco, C. D., Allan Butterfield, D., & Stella, A. M. G. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04367.x · Cited by 63 · cited 1×
“[16].”
Self-citationQian, Y., Falahatpisheh, M. H., Zheng, Y., Ramos, K. S., & Tiffany‐Castiglioni, E. (2001) · Neurotoxicity Research · doi:10.1007/bf03033212 · Cited by 62 · cited 1×
“During the ER stress response, Grp 78 binds misfolded proteins and translocates then through ER membranes for their proteasomal degradation [34].”
BackgroundOxidative modification of human ceruloplasmin by peroxyl radicals
Kang, J. H., Kim, K. S., Choi, S. Y., Kwon, H. Y., & Won, M. H. (2001) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(01)00198-2 · Cited by 60 · cited 1×
“During exposure to OS, it has been suggested that substantial CP inactivation may occur and free copper ions could be released [48, 49].”
BackgroundPark, E., Alberti, J., Mehta, P. D., Dalton, A. J., Sersen, E. A., & Schuller‐Levis, G. (2000) · Clinical Immunology · doi:10.1006/clim.2000.4834 · Cited by 58 · cited 1×
“Indeed, the proposed scenario could correlate with some characteristic features of DS including early ageing [71], neurological and cognitive impairment [72], increased risk for cancer and immunodeficiency [73, 74].”
BackgroundThe insulin‐like growth factor I system in cerebellar degeneration
Torres‐Aleman, I., Barrios, V., Lledo, A., & Berciano, J. (1996) · Annals of Neurology · doi:10.1002/ana.410390310 · Cited by 56 · cited 1×
“The present findings extend and reinforce the observation that levels of circulating insulin, IGF-I and IGFBPs are altered in many types of human neurodegenerative diseases, including major illnesses such as Alzheimer disease or stroke as well as inherited neurodegenerative diseases [55, 56].”
ResultFagan, A. M., Christopher, E., Taylor, J. W., Parsadanian, M., Spinner, M., Watson, M., Fryer, J. D., Wahrle, S., Bales, K. R., Paul, S. M., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63399-8 · Cited by 54 · cited 1×
“ApoA1 is the major apolipoprotein associated with HDL, and apoA1 deficiency in humans leads to a phenotype of low plasma HDL levels and premature atherosclerosis [61].”
BackgroundCleavage of high-molecular-weight kininogen by elastase and tryptase is inhibited by ferritin
Coffman, L. G., Brown, J. C., Johnson, D. A., Parthasarathy, N., D'Agostino, R. B., Lively, M. O., Hua, X., Tilley, S. L., Müller‐Esterl, W., Willingham, M. C., et al. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00347.2007 · Cited by 50 · cited 1×
“HK, together with prekallikrein and factor XII, comprise the contact system of coagulation [67].”
BackgroundAmniotic Fluid Proteome Analysis from Down Syndrome Pregnancies for Biomarker Discovery
Cho, C.-K. J., Smith, C. R., & Diamandis, E. P. (2010) · Journal of Proteome Research · doi:10.1021/pr100088k · Cited by 50 · cited 1×
“In addition, other groups employed proteomic technology in prenatal diagnosis to identify putative biomarkers for early and accurate detection of fetuses at risk of chromosomal abnormalities [44–46].”
BackgroundToward High-Throughput Drug Screening Using Mass Spectrometry
Maurer, H. H., & Peters, F. T. (2005) · Therapeutic Drug Monitoring · doi:10.1097/01.ftd.0000180224.19384.f0 · Cited by 47 · cited 1×
“Statistical significance was assessed by a two-tailed Student’s t-test, the method of statistical analysis most appropriate for proteomic analysis of small number of protein spots [21].”
MethodSomatomedins in Down's syndrome.
Vr, S., Kh, G., Annerén, G., Hall, K. E., & Wetterberg, L. (1983) · PubMed · Cited by 42
Di Domenico, F., Di Domenico, F., Perluigi, M., Foppoli, C., Blarzino, C., Coccia, R., De Marco, F., Butterfield, D. A., & Cini, C. (2009) · Free Radical Research · doi:10.1080/10715760902777329 · Cited by 41 · cited 1×
“All the details about the procedure are described in our previous works [18, 19].”
MethodSelf-citationDifferential expression of molecular chaperones in brain of patients with Down syndrome
Yoo, B. C., Vlkolinský, R., Engidawork, E., Cairns, N. J., Fountoulakis, M., & Lübec, G. (2001) · Electrophoresis · Cited by 39
Serum Lipid Resistance to Oxidation and Uric Acid Levels in Subjects with Down's s Syndrome
Nagyová, A., Šustrová, M., & Rašlová, K. (2000) · Physiological Research · doi:10.33549/physiolres.930000.49.227 · Cited by 32 · cited 1×
“A significant increase in oxidative DNA damage (urinary 8-OHdG), lipid peroxidation and isoprostane 8,12-iso-iPF2aVI levels [3, 5, 9–12] was reported in urine obtained from DS children and DS amniotic fluid (AF) samples, respectively, indicating a ‘‘pro-oxidant state’’ which, associated with overwhelmed antioxidant de…”
BackgroundCoenzyme Q10 and oxidative imbalance in Down syndrome: Biochemical and clinical aspects
Tiano, L., Padella, L., Carnevali, P., Gabrielli, O., Brugè, F., Principi, F., & Littarru, G. P. (2008) · BioFactors · doi:10.1002/biof.5520320119 · Cited by 30 · cited 3×
“Although OS is known to play a major role in DS [6], the molecular mechanisms underlying the pathological alterations and how the oxidative imbalance can contribute to the clinical manifestation of DS are not yet known [1].”
BackgroundSerum lipid resistance to oxidation and uric acid levels in subjects with Down's syndrome.
Nagyová, A., Šustrová, M., & Rašlová, K. (2000) · PubMed · Cited by 30
Increased superoxide dismutase and Down’s syndrome
Turrens, J. F. (2001) · Medical Hypotheses · doi:10.1054/mehy.2001.1327 · Cited by 29 · cited 1×
“It has been proposed that many of the neurological symptoms of DS result from the increased activity of SOD, even though there is still an open debate [7].”
BackgroundKolialexi, A., Vrettou, C., Traeger‐Synodinos, J., Burgemeister, R., Papantoniou, N., Kanavakis, E., Antsaklis, A. J., & Mavrou, A. (2007) · Prenatal Diagnosis · doi:10.1002/pd.1881 · Cited by 29
Marzia Perluigi, A., Giorgi, A., Blarzino, C., Marco, F. D., Foppoli, C., Domenico, F. D., Butterfield, D. A., Schininà, M. E., Cini, C., & Coccia, R. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00465.x · Cited by 29 · cited 1×
“All the details about the procedure are described in our previous works [18, 19].”
MethodSelf-citationYoo, B. C., Fountoulakis, M., Dierssen, M., & Lübec, G. (2001) · Springer eBooks · doi:10.1007/978-3-7091-6262-0_27 · Cited by 23
Helbecque, N., Codron, V., Cottel, D., & Amouyel, P. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000112176 · Cited by 23 · cited 1×
“The finding of increased oxidation of ApoA1 is in line with recent reports highlighting that ApoA dysfunction may be linked to increased susceptibility to cognitive impairment [64].”
ResultMIELL, J. P., Jauniaux, E., Langford, K., Westwood, M., White, A. E., & Jones, J. S. (1997) · Molecular Human Reproduction · doi:10.1093/molehr/3.4.343 · Cited by 19 · cited 1×
“IGFs are a family of mitogenic polypeptides that have been shown to be important determinants of fetal growth during human pregnancy[51–53].”
BackgroundKim, Y. (2010) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.0912.12035 · Cited by 18 · cited 1×
“[43].”
Oxidative Aggregation of Ceruloplasmin Induced by Hydrogen Peroxide is Prevented by Pyruvate
Aouffen, M., Paquin, J., Fürtös, A., Waldron, K. C., & Mateescu, M. (2003) · Free Radical Research · doi:10.1080/10715760310001624079 · Cited by 12 · cited 1×
“During exposure to OS, it has been suggested that substantial CP inactivation may occur and free copper ions could be released [48, 49].”
BackgroundHawn, J., Rice, C., Nichols, H. L., & McDermott, S. W. (2009) · PubMed · Cited by 11
Proteomics in prenatal diagnosis
Kolialexi, A., Tsangaris, G. T., & Mavrou, A. (2009) · Expert Review of Proteomics · doi:10.1586/epr.09.6 · Cited by 9 · cited 1×
“In addition, other groups employed proteomic technology in prenatal diagnosis to identify putative biomarkers for early and accurate detection of fetuses at risk of chromosomal abnormalities [44–46].”
BackgroundModification of Sheep Plasma Kininogen by Free Radicals
Baba, S. P., Patel, D. K., & Bano, B. (2004) · Free Radical Research · doi:10.1080/1071576042000191790 · Cited by 7 · cited 5×
“This result is consistent with previous studies showing that the properties of kininogens were altered by oxidation of their methionine residues by ROS [70].”
ResultInfluential
Research works printed but not linked: 2
- 10.1089/ars.2004.6.878 · doi:10.1089/ars.2004.6.878 · Paper page
- 10.1002/1522-2683()22:6<1233::aid-elps1233>3.0.co;2-m · doi:10.1002/1522-2683()22:6<1233::aid-elps1233>3.0.co;2-m
Cited by
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
Butterfield, D. A., & Halliwell, B. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0132-6 · Cited by 1,954
Self-citationButterfield, D. A., & Boyd-Kimball, D. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170543 · Cited by 403
“Oxidative stress occurs extremely early in DS [165]: we reported that amniotic fluid of mothers carrying DS fetuses show increased oxidative stress, and redox proteomics identified oxidatively modified proteins in amniotic fluid that are consistent with the spectrum of phenotypes associated with DS [166].”
ResultSelf-citationCellular Senescence in Neurodegenerative Diseases
Martínez-Cué, C., & Rueda, N. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00016 · Cited by 281
“Furthermore, mitochondrial dysfunction is also present in DS cells during embryonic life (Perluigi et al., 2011), leading to profound alterations in energy metabolism due to the reduced synthesis of ATP synthesis (Valenti et al.”
BackgroundPerluigi, M., Coccia, R., & Butterfield, D. A. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4406 · Cited by 229
Self-citationOxidative Stress and Down Syndrome: A Route toward Alzheimer-Like Dementia
Perluigi, M., & Butterfield, D. A. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/724904 · Cited by 181
“The identified proteins are involved in iron homeostasis (ceruloplasmin and transferin), lipid metabolism (Zinc-alpha2-glycoprotein, retinol binding protein 4 and Apolipoprotein A1), and inflammation (Complement C9, Alpha-1B-glycoprotein, Collagen alpha-1 V chain) with critical relevance in the clinical outcome of DS…”
BackgroundSelf-citation
Metadata
- Authors
- Perluigi, M., di Domenico, F., Fiorini, A., Cocciolo, A., Giorgi, A., Foppoli, C., Butterfield, D. A., Giorlandino, M., Giorlandino, C., Eugenia Schininà, M., & Coccia, R.
- Affiliations
- Sapienza University of Rome (IT)
- Institute of Molecular Biology and Pathology (IT)
- University of Kentucky (US)
- Altamedica Artemisia (IT)
- Corresponding author
- Butterfield, D. Allan
- Venue
- PROTEOMICS – Clinical Applications
- Publisher
- Wiley
- Published
- 2011-02-24
- Volume
- 5
- Issue
- 3-4
- Pages
- 167-178
- ISSN
- 1862-8346 (ISSN-L)
- 1862-8354
- OpenAlex
- W2069717482
- Cited by
- 97
- References
- 75
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 1 · 2023: 5 · 2022: 6 · 2021: 4 · 2020: 10 · 2019: 4 · 2018: 7 · 2017: 7 · 2016: 6 · 2015: 5 · 2014: 9 · 2013: 6 · 2012: 10
- FWCI
- 11.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- PROTEOMICS - CLINICAL APPLICATIONS (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Funders
- Artemisia Medical Center of Rome
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- Down syndrome, oxidative stress, amniotic fluid, protein carbonylation, glutathione, thioredoxin, heat shock proteins, redox proteomics, lipid peroxidation, iron homeostasis, ceruloplasmin, zinc-alpha2-glycoprotein, retinol-binding protein 4, apolipoprotein A-I, complement C9, alpha-1B-glycoprotein, early pregnancy
- MeSH terms
- Adult, Amniotic Fluid, Down Syndrome, Female, Humans, Oxidation-Reduction, Phenotype, Pregnancy, Pregnancy Trimester, First, Proteins, Retrospective Studies, Sensitivity and Specificity, Oxidative Stress, Proteomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.